Thomas Chauncey

Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell Lymphoma.

Authors:

Solomon A Graf Ryan D Cassaday Karolyn Morris Jenna M Voutsinas Qian Vicky Wu Sanaz Behnia Ryan C Lynch Elizabeth Krakow Heather Rasmussen Thomas R Chauncey Sandra Kanan Lorinda Soma Stephen D Smith Ajay K Gopal

Clin Lymphoma Myeloma Leuk 2020 Dec 3. Epub 2020 Dec 3.

Division of Medical Oncology, University of Washington Medicine, Seattle, WA; Clinical Research Division, Fred Hutch Cancer Research Center, Seattle, WA. Electronic address:

View Article and Find Full Text PDF

December 2020

Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS).

Authors:

Heather Klocke Zhao Ming Dong Craig O'Brien Nicholas Burwick Robert E Richard Daniel Y Wu Thomas R Chauncey Solomon A Graf

Case Rep Hematol 2020 10;2020:8811673. Epub 2020 Oct 10.

Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.

View Article and Find Full Text PDF

October 2020

AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report.

Biomark Res 2020 12;8:29. Epub 2020 Aug 12.

Clinical Research Division, Fred Hutch, 1100 Fairview Ave N, D5-112, Seattle, WA 98109 USA.

View Article and Find Full Text PDF

August 2020

Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donors.

Authors:

Brian Kornblit Barry E Storer Niels S Andersen Michael B Maris Thomas R Chauncey Effie W Petersdorf Ann E Woolfrey Mary E D Flowers Rainer Storb David G Maloney Brenda M Sandmaier

Blood 2020 Sep;136(13):1499-1506

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article and Find Full Text PDF

September 2020

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.

Haematologica 2020 Jun 4. Epub 2020 Jun 4.

Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA.

View Article and Find Full Text PDF

June 2020

Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience.

Authors:

Aaron Wu Solomon A Graf Nicholas Burwick Jonathan E Grim Zhao Ming Dong Robert E Richard Thomas R Chauncey

Blood Res 2020 Mar 30;55(1):57-61. Epub 2020 Mar 30.

Department of Hospital and Specialty Medicine, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.

View Article and Find Full Text PDF

March 2020

Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia.

Authors:

Elizabeth F Krakow Boglarka Gyurkocza Barry E Storer Thomas R Chauncey Jeannine S McCune Jerald P Radich Michelle E Bouvier Elihu H Estey Rainer Storb David G Maloney Brenda M Sandmaier

Am J Hematol 2020 01 8;95(1):48-56. Epub 2019 Nov 8.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article and Find Full Text PDF

January 2020

Assessing Cachexia Acutely after Autologous Stem Cell Transplant.

Authors:

Lindsey J Anderson Chelsea Yin Raul Burciaga Jonathan Lee Stephanie Crabtree Dorota Migula Kelsey Geiss-Wessel Haiming M Liu Solomon A Graf Thomas R Chauncey Jose M Garcia

Cancers (Basel) 2019 Sep 4;11(9). Epub 2019 Sep 4.

Geriatric Research, Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, 98108 WA, USA.

View Article and Find Full Text PDF

September 2019

Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience.

Authors:

Mazyar Shadman David G Maloney Barry Storer Brenda M Sandmaier Thomas R Chauncey Niels Smedegaard Andersen Dietger Niederwieser Judith Shizuru Benedetto Bruno Michael A Pulsipher Richard T Maziarz Edward D Agura Parameswaran Hari Amelia A Langston Michael B Maris Peter A McSweeney Rainer Storb Mohamed L Sorror

Bone Marrow Transplant 2020 01 3;55(1):172-181. Epub 2019 Sep 3.

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article and Find Full Text PDF

January 2020

Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.

Authors:

Brenda M Sandmaier Brian Kornblit Barry E Storer Gitte Olesen Michael B Maris Amelia A Langston Jonathan A Gutman Soeren L Petersen Thomas R Chauncey Wolfgang A Bethge Michael A Pulsipher Ann E Woolfrey Marco Mielcarek Paul J Martin Fred R Appelbaum Mary E D Flowers David G Maloney Rainer Storb

Lancet Haematol 2019 Aug 24;6(8):e409-e418. Epub 2019 Jun 24.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.

View Article and Find Full Text PDF

August 2019

Second allogeneic hematopoietic cell transplantation for relapse after first allografts.

Authors:

Boglarka Gyurkocza Rainer Storb Thomas R Chauncey David G Maloney Barry E Storer Brenda M Sandmaier

Leuk Lymphoma 2019 07 22;60(7):1758-1766. Epub 2019 Jan 22.

c Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA.

View Article and Find Full Text PDF

July 2019

Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasms.

Authors:

Federico Monaco Bart L Scott Thomas R Chauncey Finn B Petersen Barry E Storer Frederic Baron Mary E Flowers H Joachim Deeg David G Maloney Rainer Storb Brenda M Sandmaier

Haematologica 2019 06 10;104(6):1221-1229. Epub 2019 Jan 10.

Fred Hutchinson Cancer Research Center, Seattle, WA, USA

View Article and Find Full Text PDF

June 2019

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma.

Authors:

Enrico Maffini Barry E Storer Brenda M Sandmaier Benedetto Bruno Firoozeh Sahebi Judith A Shizuru Thomas R Chauncey Parameswaran Hari Thoralf Lange Michael A Pulsipher Peter A McSweeney Leona Holmberg Pamela S Becker Damian J Green Marco Mielcarek David G Maloney Rainer Storb

Haematologica 2019 02 27;104(2):380-391. Epub 2018 Sep 27.

Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA

View Article and Find Full Text PDF

February 2019

Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies.

Authors:

Abby Statler Megan Othus Harry P Erba Thomas R Chauncey Jerald P Radich Steven Coutre Anjali Advani Sucha Nand Farhad Ravandi Sudipto Mukherjee Mikkael A Sekeres

Blood 2018 06 4;131(25):2782-2788. Epub 2018 Apr 4.

Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.

View Article and Find Full Text PDF

June 2018

Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report.

Authors:

Era L Pogosova-Agadjanyan Anna Moseley Megan Othus Frederick R Appelbaum Thomas R Chauncey I-Ming L Chen Harry P Erba John E Godwin Min Fang Kenneth J Kopecky Alan F List Galina L Pogosov Jerald P Radich Cheryl L Willman Brent L Wood Soheil Meshinchi Derek L Stirewalt

Biopreserv Biobank 2018 Feb 27;16(1):42-52. Epub 2017 Nov 27.

1 Clinical Research Division , Fred Hutch, Seattle, Washington.

View Article and Find Full Text PDF

February 2018

Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial.

Authors:

Merav Bar Mary E D Flowers Barry E Storer Thomas R Chauncey Michael A Pulsipher Monica S Thakar Wolfgang Bethge Rainer Storb David G Maloney Brenda M Sandmaier

Biol Blood Marrow Transplant 2018 02 12;24(2):308-313. Epub 2017 Oct 12.

Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington. Electronic address:

View Article and Find Full Text PDF

February 2018

CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation.

Authors:

Frederick L Locke Joseph Pidala Barry Storer Paul J Martin Michael A Pulsipher Thomas R Chauncey Niels Jacobsen Nicolaus Kröger Irwin Walker Susan Light Bronwen E Shaw Francisca Beato Ginna G Laport Auayporn Nademanee Armand Keating Gerard Socie Claudio Anasetti

Biol Blood Marrow Transplant 2017 Mar 19;23(3):405-411. Epub 2016 Dec 19.

Blood and Marrow Transplantation Program, Moffitt Cancer Center, Tampa, Florida. Electronic address:

View Article and Find Full Text PDF

March 2017

Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma.

Authors:

Solomon A Graf Jennifer E Vaughn Thomas R Chauncey Barry E Storer Ajay K Gopal Leona A Holmberg Jeannine S McCune William I Bensinger David G Maloney Oliver W Press Rainer Storb Mohamed L Sorror

Biol Blood Marrow Transplant 2016 09 14;22(9):1582-1587. Epub 2016 Jun 14.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article and Find Full Text PDF

September 2016

High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma.

Authors:

Ryan D Cassaday Philip A Stevenson Theodore A Gooley Thomas R Chauncey John M Pagel Joseph Rajendran Brian G Till Mary Philip Johnnie J Orozco William I Bensinger Leona A Holmberg Andrei R Shustov Damian J Green Stephen D Smith Edward N Libby David G Maloney Oliver W Press Ajay K Gopal

Br J Haematol 2015 Dec 12;171(5):788-97. Epub 2015 Oct 12.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA.

View Article and Find Full Text PDF

December 2015

Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission.

Biol Blood Marrow Transplant 2016 Feb 5;22(2):380-385. Epub 2015 Sep 5.

Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington. Electronic address:

View Article and Find Full Text PDF

February 2016

Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

Authors:

Jennifer E Vaughn Mohamed L Sorror Barry E Storer Thomas R Chauncey Michael A Pulsipher Richard T Maziarz Michael B Maris Parameswaran Hari Ginna G Laport Georg N Franke Edward D Agura Amelia A Langston Andrew R Rezvani Rainer Storb Brenda M Sandmaier David G Maloney

Cancer 2015 Oct 24;121(20):3709-16. Epub 2015 Jul 24.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article and Find Full Text PDF

October 2015

Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases.

Authors:

Ashley T Evans Keith R Loeb Howard M Shulman Sajida Hassan Wan Chong Qiu David M Hockenbery George N Ioannou Thomas R Chauncey David R Gretch George B McDonald

Am J Surg Pathol 2015 Feb;39(2):212-20

Departments of *Medicine †Pathology §Laboratory Medicine, University of Washington School of Medicine ‡Clinical Research Division, Fred Hutchinson Cancer Research Center ∥VA Puget Sound Health Care System, Seattle, WA.

View Article and Find Full Text PDF

February 2015

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation.

Authors:

Brian Kornblit David G Maloney Barry E Storer Michael B Maris Lars Vindeløv Parameswaran Hari Amelia A Langston Michael A Pulsipher Wolfgang A Bethge Thomas R Chauncey Thoralf Lange Finn B Petersen Kai Hübel Ann E Woolfrey Mary E D Flowers Rainer Storb Brenda M Sandmaier

Haematologica 2014 Oct 1;99(10):1624-31. Epub 2014 Aug 1.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Division of Oncology, Department of Medicine, University of Washington, Seattle, WA, USA

View Article and Find Full Text PDF

October 2014

Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity.

Authors:

Colin Phipps Ajay K Gopal Barry E Storer Ryan D Cassaday Oliver W Press Brian G Till John M Pagel Maria C Palanca-Wessels Mary Philip William I Bensinger Leona A Holmberg Andrei R Shustov Damian J Green Thomas Chauncey David G Maloney Edward N Libby

Leuk Lymphoma 2015 Jan 17;56(1):92-6. Epub 2014 Jun 17.

Clinical Research Division, Fred Hutchinson Cancer Research Center , Seattle, WA , USA.

View Article and Find Full Text PDF

January 2015

CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab.

Authors:

Min Yan Zhaoming Dong Frank Zhao Thomas Chauncey Delva Deauna-Limayo Jessica Wang-Rodriguez Dayu Liu Huan-You Wang Renate Pilz

Eur J Haematol 2014 Jul 1;93(1):77-80. Epub 2014 Apr 1.

Moores Cancer Center, University of California San Diego Health System, La Jolla, CA, USA.

View Article and Find Full Text PDF

July 2014

Specific features identify patients with relapsed or refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation.

Authors:

Ryan D Cassaday Katherine A Guthrie Elizabeth L Budde Leslie Thompson Brian G Till Oliver W Press Thomas R Chauncey John M Pagel Stephen H Petersdorf Maria Corinna Palanca-Wessels Mary Philip William I Bensinger Leona A Holmberg Andrei Shustov Damian J Green Edward N Libby David G Maloney Ajay K Gopal

Biol Blood Marrow Transplant 2013 Sep 17;19(9):1403-6. Epub 2013 Jul 17.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

View Article and Find Full Text PDF

September 2013

Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial.

Authors:

Brian Kornblit David G Maloney Rainer Storb Jan Storek Parameswaran Hari Vladan Vucinic Richard T Maziarz Thomas R Chauncey Michael A Pulsipher Benedetto Bruno Finn B Petersen Wolfgang A Bethge Kai Hübel Michelle E Bouvier Takahiro Fukuda Barry E Storer Brenda M Sandmaier

Biol Blood Marrow Transplant 2013 Sep 11;19(9):1340-7. Epub 2013 Jun 11.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

View Article and Find Full Text PDF

September 2013

Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose.

Authors:

Merav Bar Brenda M Sandmaier Yoshihiro Inamoto Benedetto Bruno Parameswaran Hari Thomas Chauncey Paul J Martin Rainer Storb David G Maloney Barry Storer Mary E D Flowers

Biol Blood Marrow Transplant 2013 Jun 21;19(6):949-57. Epub 2013 Mar 21.

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article and Find Full Text PDF

June 2013

Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.

J Clin Oncol 2013 Apr 11;31(12):1530-8. Epub 2013 Mar 11.

University of Washington, USA.

View Article and Find Full Text PDF

April 2013

Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow.

Authors:

Marco Mielcarek Barry Storer Paul J Martin Stephen J Forman Robert S Negrin Mary E Flowers Yoshihiro Inamoto Thomas R Chauncey Rainer Storb Frederick R Appelbaum William I Bensinger

Blood 2012 Mar 3;119(11):2675-8. Epub 2012 Feb 3.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article and Find Full Text PDF

March 2012

The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.

Authors:

Bart L Scott Ted A Gooley Mohamed L Sorror Andrew R Rezvani Michael L Linenberger Jonathan Grim Brenda M Sandmaier David Myerson Thomas R Chauncey Rainer Storb Veronika Buxhofer-Ausch Jerald P Radich Frederick R Appelbaum H Joachim Deeg

Blood 2012 Mar 10;119(11):2657-64. Epub 2012 Jan 10.

Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

March 2012

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.

JAMA 2011 Nov;306(17):1874-83

Transplantation Biology Program, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

View Article and Find Full Text PDF

November 2011

Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation.

Authors:

Lihua E Budde Katherine A Guthrie Brian G Till Oliver W Press Thomas R Chauncey John M Pagel Steven H Petersdorf William I Bensinger Leona A Holmberg Andrei R Shustov Damian J Green David G Maloney Ajay K Gopal

J Clin Oncol 2011 Aug 5;29(22):3023-9. Epub 2011 Jul 5.

825 Eastlake Ave E, G3-200, Seattle, WA, USA.

View Article and Find Full Text PDF

August 2011

Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftment.

Authors:

Nandita Khera Jack Jinneman Barry E Storer Shelly Heimfeld Megan M O'Meara Thomas R Chauncey Stephanie J Lee Michael Linenberger

Biol Blood Marrow Transplant 2012 Feb 15;18(2):220-8. Epub 2011 Jun 15.

Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. North, Seattle, WA 98109, USA.

View Article and Find Full Text PDF

February 2012

Cytomegalovirus viral load and virus-specific immune reconstitution after peripheral blood stem cell versus bone marrow transplantation.

Authors:

Abraham Guerrero Stanley R Riddell Jan Storek Terry Stevens-Ayers Barry Storer John A Zaia Stephen Forman Robert S Negrin Thomas Chauncey William Bensinger Michael Boeckh

Biol Blood Marrow Transplant 2012 Jan 20;18(1):66-75. Epub 2011 May 20.

Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.

View Article and Find Full Text PDF

January 2012

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.

Authors:

Ron Ram Rainer Storb Brenda M Sandmaier David G Maloney Ann Woolfrey Mary E D Flowers Michael B Maris Ginna G Laport Thomas R Chauncey Thoralf Lange Amelia A Langston Barry Storer George E Georges

Haematologica 2011 Aug 20;96(8):1113-20. Epub 2011 Apr 20.

Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, WA 98109, USA.

View Article and Find Full Text PDF

August 2011

Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.

J Clin Oncol 2010 Jun 3;28(17):2859-67. Epub 2010 May 3.

Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA

View Article and Find Full Text PDF

June 2010

Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.

Authors:

Hirohisa Nakamae Barry E Storer Rainer Storb Jan Storek Thomas R Chauncey Michael A Pulsipher Finn B Petersen James C Wade Michael B Maris Benedetto Bruno Jens Panse Effie Petersdorf Ann Woolfrey David G Maloney Brenda M Sandmaier

Biol Blood Marrow Transplant 2010 Mar 10;16(3):384-94. Epub 2009 Nov 10.

Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

March 2010

Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.

Authors:

Thomas R Chauncey Holly Gundacker Mazyar Shadman Alan F List Shaker R Dakhil Harry P Erba Marilyn L Slovak I-Ming Chen Cheryl L Willman Kenneth J Kopecky Frederick R Appelbaum

Br J Haematol 2010 Jan 11;148(1):48-58. Epub 2009 Oct 11.

University of Washington, Seattle, 98108, USA.

View Article and Find Full Text PDF

January 2010

What is the role for donor natural killer cells after nonmyeloablative conditioning?

Authors:

Frédéric Baron Effie W Petersdorf Ted Gooley Brenda M Sandmaier Mari Malkki Thomas R Chauncey David G Maloney Rainer Storb

Biol Blood Marrow Transplant 2009 May;15(5):580-8

Giga Research, University of Liège, Liège, Belgium.

View Article and Find Full Text PDF

May 2009

Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.

Authors:

Marcello Rotta Barry E Storer Firoozeh Sahebi Judith A Shizuru Benedetto Bruno Thoralf Lange Edward D Agura Peter A McSweeney Michael A Pulsipher Parameswaran Hari Richard T Maziarz Thomas R Chauncey Frederick R Appelbaum Mohamed L Sorror William Bensinger Brenda M Sandmaier Rainer F Storb David G Maloney

Blood 2009 Apr 17;113(14):3383-91. Epub 2008 Nov 17.

Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article and Find Full Text PDF

April 2009

Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

Authors:

Mohamed L Sorror Barry E Storer Brenda M Sandmaier Michael Maris Judith Shizuru Richard Maziarz Edward Agura Thomas R Chauncey Michael A Pulsipher Peter A McSweeney James C Wade Benedetto Bruno Amelia Langston Jerald Radich Dietger Niederwieser Karl G Blume Rainer Storb David G Maloney

J Clin Oncol 2008 Oct 15;26(30):4912-20. Epub 2008 Sep 15.

Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

October 2008

Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.

Authors:

Andrew R Rezvani Lalitha Norasetthada Ted Gooley Mohamed Sorror Michelle E Bouvier Firoozeh Sahebi Edward Agura Thomas Chauncey Richard T Maziarz Michael Maris Judith Shizuru Benedetto Bruno Christopher Bredeson Thoralf Lange Andrew Yeager Brenda M Sandmaier Rainer F Storb David G Maloney

Br J Haematol 2008 Nov 28;143(3):395-403. Epub 2008 Aug 28.

Transplantation Biology Program, Fred Hutchinson Cancer Research Center & University of Washington, Seattle, WA 98109, USA.

View Article and Find Full Text PDF

November 2008

Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes.

Authors:

Bart L Scott J Y Park H Joachim Deeg Kieren A Marr Michael Boeckh Thomas R Chauncey Frederick R Appelbaum Rainer Storb Barry E Storer

Biol Blood Marrow Transplant 2008 Jul;14(7):799-806

Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article and Find Full Text PDF

July 2008

Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.

Authors:

Mohamed Sorror Barry Storer Brenda M Sandmaier David G Maloney Thomas R Chauncey Amelia Langston Richard T Maziarz Michael Pulsipher Peter A McSweeney Rainer Storb

Cancer 2008 May;112(9):1992-2001

Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

May 2008

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.

Biol Blood Marrow Transplant 2008 Feb;14(2):246-55

Stanford University Medical Center, Stanford, California 94305-5623, USA.

View Article and Find Full Text PDF

February 2008

Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.

Authors:

Andrew R Rezvani Barry Storer Michael Maris Mohamed L Sorror Edward Agura Richard T Maziarz James C Wade Thomas Chauncey Stephen J Forman Thoralf Lange Judith Shizuru Amelia Langston Michael A Pulsipher Brenda M Sandmaier Rainer Storb David G Maloney

J Clin Oncol 2008 Jan 3;26(2):211-7. Epub 2007 Dec 3.

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, MS D1-100, Seattle, WA 98109, USA.

View Article and Find Full Text PDF

January 2008

Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.

Authors:

Frédéric Baron Brenda M Sandmaier Barry E Storer Michael B Maris Amelia A Langston Thoralf Lange Effie Petersdorf Wolfgang Bethge Richard T Maziarz Peter A McSweeney Michael A Pulsipher James C Wade Thomas R Chauncey Judith A Shizuru Mohamed L Sorror Ann E Woolfrey David G Maloney Rainer Storb

Biol Blood Marrow Transplant 2007 Sep 20;13(9):1041-8. Epub 2007 Jul 20.

University of Liège, Liège, Belgium.

View Article and Find Full Text PDF

September 2007

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

Blood 2007 Oct 26;110(7):2744-8. Epub 2007 Jun 26.

Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

October 2007

Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.

Authors:

George E Georges Michael B Maris David G Maloney Brenda M Sandmaier Mohamed L Sorror Judith A Shizuru Thoralf Lange Edward D Agura Benedetto Bruno Peter A McSweeney Michael A Pulsipher Thomas R Chauncey Marco Mielcarek Barry E Storer Rainer Storb

Biol Blood Marrow Transplant 2007 Apr 1;13(4):423-32. Epub 2007 Feb 1.

Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, D1-100, Seattle, WA 98109, USA.

View Article and Find Full Text PDF

April 2007

Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.

Authors:

Frédéric Baron Rainer Storb Barry E Storer Michael B Maris Dietger Niederwieser Judith A Shizuru Thomas R Chauncey Benedetto Bruno Stephen J Forman Peter A McSweeney Richard T Maziarz Michael A Pulsipher Edward D Agura James Wade Mohamed Sorror David G Maloney Brenda M Sandmaier

J Clin Oncol 2006 Sep 8;24(25):4150-7. Epub 2006 Aug 8.

Fred Hutchinson Cancer Research Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

September 2006

Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.

Authors:

Lauri Burroughs Marco Mielcarek Wendy Leisenring Brenda M Sandmaier David G Maloney Frédéric Baron Paul J Martin Mary E D Flowers Stephen J Forman Thomas R Chauncey Benedetto Bruno Rainer Storb

Transplantation 2006 Mar;81(6):818-25

Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, WA 98109, USA.

View Article and Find Full Text PDF

March 2006

Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.

Authors:

Michael B Maris Brenda M Sandmaier Barry E Storer David G Maloney Judith A Shizuru Edward Agura Constanze Kliem Michael Pulsipher Richard T Maziarz Peter A McSweeney James Wade Amelia A Langston Thomas R Chauncey Benedetto Bruno Karl G Blume Rainer Storb

Biol Blood Marrow Transplant 2006 Apr;12(4):454-65

Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article and Find Full Text PDF

April 2006

Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.

J Clin Oncol 2006 Jan 12;24(3):444-53. Epub 2005 Dec 12.

University of Leipzig, Leipzig, Germany.

View Article and Find Full Text PDF

January 2006

Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.

Authors:

Christoph Kahl Wendy Leisenring H Joachim Deeg Thomas R Chauncey Mary E D Flowers Paul J Martin Jean E Sanders Rainer Storb

Br J Haematol 2005 Sep;130(5):747-51

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article and Find Full Text PDF

September 2005

Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation.

Authors:

Marco Mielcarek Lauri Burroughs Wendy Leisenring Razvan Diaconescu Paul J Martin Brenda M Sandmaier David G Maloney Michael B Maris Thomas R Chauncey Judith A Shizuru Karl G Blume Ute Hegenbart Dietger Niederwieser Stephen Forman Benedetto Bruno Ann Woolfrey Rainer Storb

Br J Haematol 2005 May;129(3):381-91

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

May 2005

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia.

Authors:

Frédéric Baron Michael B Maris Barry E Storer Brenda M Sandmaier Monic J Stuart Peter A McSweeney Jerald P Radich Michael A Pulsipher Edward D Agura Thomas R Chauncey David G Maloney Judith A Shizuru Rainer Storb

Biol Blood Marrow Transplant 2005 Apr;11(4):272-9

Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article and Find Full Text PDF

April 2005

Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.

J Clin Oncol 2005 Jun 4;23(16):3819-29. Epub 2005 Apr 4.

Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, D1-100, PO Box 19024, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

June 2005

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.

Authors:

Frédéric Baron Michael B Maris Brenda M Sandmaier Barry E Storer Mohamed Sorror Razvan Diaconescu Ann E Woolfrey Thomas R Chauncey Mary E D Flowers Marco Mielcarek David G Maloney Rainer Storb

J Clin Oncol 2005 Mar;23(9):1993-2003

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D1-100, PO Box 19024, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

March 2005

Effects of race on survival after stem cell transplantation.

Authors:

Marco Mielcarek Theodore Gooley Paul J Martin Thomas R Chauncey Bessie A Young Rainer Storb Beverly Torok-Storb

Biol Blood Marrow Transplant 2005 Mar;11(3):231-9

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article and Find Full Text PDF

March 2005

Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia.

Authors:

Vivian G Oehler Jerald P Radich Barry Storer Karl G Blume Thomas Chauncey Reginald Clift David S Snyder Stephen J Forman Mary E D Flowers Paul Martin Katherine A Guthrie Robert S Negrin Frederick R Appelbaum William Bensinger

Biol Blood Marrow Transplant 2005 Feb;11(2):85-92

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article and Find Full Text PDF

February 2005

Targeted busulfan and cyclophosphamide as compared to busulfan and TBI as preparative regimens for transplantation in patients with advanced MDS or transformation to AML.

Authors:

Bart Scott H Joachim Deeg Barry Storer Thomas Chauncey Stephen Petersdorf John Slattery Frederick Appelbaum

Leuk Lymphoma 2004 Dec;45(12):2409-17

Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

December 2004

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma.

Authors:

Michael B Maris Brenda M Sandmaier Barry E Storer Thomas Chauncey Monic Jain Stuart Richard T Maziarz Edward Agura Amelia A Langston Michael Pulsipher Rainer Storb David G Maloney

Blood 2004 Dec 10;104(12):3535-42. Epub 2004 Aug 10.

Fred Hutchinson Cancer Research Center, the University of Washington, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

December 2004

Autologous bone marrow transplantation improves disease free survival but not overall survival in people with acute myeloid leukaemia.

Authors:

Thomas R Chauncey

Cancer Treat Rev 2004 Aug;30(5):483-7

Marrow Transplant Unit, VA Puget Sound Health Care System, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article and Find Full Text PDF

August 2004

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

Authors:

Frédéric Baron Jennifer E Baker Rainer Storb Theodore A Gooley Brenda M Sandmaier Michael B Maris David G Maloney Shelly Heimfeld Dmitrij Oparin Eustacia Zellmer Jerald P Radich F Carl Grumet Karl G Blume Thomas R Chauncey Marie-Térèse Little

Blood 2004 Oct 29;104(8):2254-62. Epub 2004 Jun 29.

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D1-100, PO Box 19024, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

October 2004

Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome.

Authors:

Wolfgang A Bethge Barry E Storer Michael B Maris Mary E D Flowers David G Maloney Thomas R Chauncey Ann E Woolfrey Rainer Storb Brenda M Sandmaier

Exp Hematol 2003 Oct;31(10):974-80

Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, Washington 98109-1024, USA.

View Article and Find Full Text PDF

October 2003

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.

Authors:

Wolfgang A Bethge Ute Hegenbart Monic J Stuart Barry E Storer Michael B Maris Mary E D Flowers David G Maloney Thomas Chauncey Benedetto Bruno Ed Agura Stephen J Forman Karl G Blume Dietger Niederwieser Rainer Storb Brenda M Sandmaier

Blood 2004 Feb 2;103(3):790-5. Epub 2003 Oct 2.

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D1-100, PO Box 19024, Seattle, WA 98109, USA.

View Article and Find Full Text PDF

February 2004

Allogeneic hematopoietic stem cell transplantation for myelofibrosis.

Authors:

H Joachim Deeg Theodore A Gooley Mary E D Flowers George E Sale John T Slattery Claudio Anasetti Thomas R Chauncey Kristine Doney George E Georges Hans-Peter Kiem Paul J Martin Effie W Petersdorf Jerald Radich Jean E Sanders Brenda M Sandmaier E Houston Warren Robert P Witherspoon Rainer Storb Frederick R Appelbaum

Blood 2003 Dec 14;102(12):3912-8. Epub 2003 Aug 14.

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D1-100, PO Box 19024, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

December 2003

Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia.

Authors:

Kristine Doney Hans Hägglund Wendy Leisenring Thomas Chauncey Frederick R Appelbaum Rainer Storb

Biol Blood Marrow Transplant 2003 Jul;9(7):472-81

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D5-280, P.O. Box 19024, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

July 2003

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.

Authors:

David G Maloney Arthur J Molina Firoozeh Sahebi Keith E Stockerl-Goldstein Brenda M Sandmaier William Bensinger Barry Storer Ute Hegenbart George Somlo Thomas Chauncey Benedetto Bruno Frederick R Appelbaum Karl G Blume Stephen J Forman Peter McSweeney Rainer Storb

Blood 2003 Nov 10;102(9):3447-54. Epub 2003 Jul 10.

Fred Hutchinson Cancer Research Center, University of Washington, and VA Medical Center, Seattle, USA.

View Article and Find Full Text PDF

November 2003

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.

Authors:

Michael B Maris Dietger Niederwieser Brenda M Sandmaier Barry Storer Monic Stuart David Maloney Effie Petersdorf Peter McSweeney Michael Pulsipher Ann Woolfrey Thomas Chauncey Ed Agura Shelly Heimfeld John Slattery Ute Hegenbart Claudio Anasetti Karl Blume Rainer Storb

Blood 2003 Sep 5;102(6):2021-30. Epub 2003 Jun 5.

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D1-100, PO Box 19024, Seattle, WA 98109-1024.

View Article and Find Full Text PDF

September 2003

Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant.

Authors:

Lyle C Feinstein Brenda M Sandmaier David G Maloney Michael B Maris Theodore A Gooley Thomas R Chauncey Ute Hegenbart Peter A McSweeney Monic J Stuart Stephen J Forman Edward A Agura Michael A Pulsipher Karl G Blume Dietger W Niederwieser Rainer F Storb

Biol Blood Marrow Transplant 2003 Apr;9(4):266-72

Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington 98109-1024, USA.

View Article and Find Full Text PDF

April 2003

HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen.

Authors:

Jerald P Radich Ted Gooley William Bensinger Thomas Chauncey Reginald Clift Mary Flowers Paul Martin John Slattery Debbie Sultan Frederick R Appelbaum

Blood 2003 Jul 20;102(1):31-5. Epub 2003 Feb 20.

Clinical Research Division, Fred Hutchinson Cancer Research Center, D4-100, 1100 Fairview Ave N, Seattle, WA 98109, USA.

View Article and Find Full Text PDF

July 2003

Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission.

Authors:

Lyle C Feinstein Brenda M Sandmaier Ute Hegenbart Peter A McSweeney David G Maloney Theodore A Gooley Michael B Maris Thomas R Chauncey Benedetto Bruno Frederick R Appelbaum Dietger W Niederwieser Rainer F Storb

Br J Haematol 2003 Jan;120(2):281-8

Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article and Find Full Text PDF

January 2003

Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.

Authors:

J Maciej Zaucha Marco Mielcarek Alessandra Takatu Marie-Terese Little Theodore Gooley Jennifer Baker David G Maloney Brenda M Sandmaier Michael Maris Thomas Chauncey Rainer Storb Beverly Torok-Storb

Br J Haematol 2002 Dec;119(3):740-50

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article and Find Full Text PDF

December 2002

Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.

Int J Hematol 2002 Aug;76 Suppl 1:184-9

Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, USA.

View Article and Find Full Text PDF

August 2002

Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors.

Authors:

Kai Hübel Rachel A Carter W Conrad Liles David C Dale Thomas H Price Raleigh A Bowden Scott D Rowley Thomas R Chauncey William I Bensinger Michael Boeckh

Transfusion 2002 Nov;42(11):1414-21

Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.

View Article and Find Full Text PDF

November 2002

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases.

Authors:

Dietger Niederwieser Michael Maris Judith A Shizuru Effie Petersdorf Ute Hegenbart Brenda M Sandmaier David G Maloney Barry Storer Thoralf Lange Thomas Chauncey Michael Deininger Wolfram Pönisch Claudio Anasetti Ann Woolfrey Marie-Terese Little Karl G Blume Peter A McSweeney Rainer F Storb

Blood 2003 Feb 3;101(4):1620-9. Epub 2002 Oct 3.

Division of Hematology and Oncology, University of Leipzig, Germany.

View Article and Find Full Text PDF

February 2003

Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation.

Authors:

Uwe Platzbecker Ted Gooley Claudio Anasetti Frederick R Appelbaum Bruce Clurman Kris Doney Thomas Chauncey Mary E D Flowers David Myerson Jerald P Radich Rainer Storb Robert P Witherspoon H Joachim Deeg

Leuk Lymphoma 2002 Jul;43(7):1409-14

Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

July 2002

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study.

Authors:

Christian Junghanss Kieren A Marr Rachel A Carter Brenda M Sandmaier Michael B Maris David G Maloney Thomas Chauncey Peter A McSweeney Rainer Storb

Biol Blood Marrow Transplant 2002 ;8(9):512-20

Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article and Find Full Text PDF

June 2003

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

Authors:

H Joachim Deeg Barry Storer John T Slattery Claudio Anasetti Kristine C Doney John A Hansen Hans-Peter Kiem Paul J Martin Effie Petersdorf Jerald P Radich Jean E Sanders Howard M Shulman Edus H Warren Robert P Witherspoon Eileen M Bryant Thomas R Chauncey Lisa Getzendaner Rainer Storb Frederick R Appelbaum

Blood 2002 Aug;100(4):1201-7

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article and Find Full Text PDF

August 2002

Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation.

Authors:

Fulvio Crippa Leona Holmberg Rachel A Carter Heather Hooper Kieren A Marr William Bensinger Thomas Chauncey Lawrence Corey Michael Boeckh

Biol Blood Marrow Transplant 2002 ;8(5):281-9

Fred Hutchinson Cancer Research Center, Seattle Washington 98109-1024, USA.

View Article and Find Full Text PDF

July 2003

Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives.

Authors:

Marco Mielcarek Brenda M Sandmaier David G Maloney Michael Maris Peter A McSweeney Ann Woolfrey Thomas Chauncey Lyle Feinstein Dietger Niederwieser Karl G Blume Stephen Forman Beverly Torok-Storb Rainer Storb

J Clin Immunol 2002 Mar;22(2):70-4

Fred Hutchinson Cancer Research Center, University of Washington, School of Medicine, Seattle, Washington 98109-1024, USA.

View Article and Find Full Text PDF

March 2002

Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality.

Biol Blood Marrow Transplant 2002 ;8(3):161-9

Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article and Find Full Text PDF

June 2003

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study.

Authors:

Christian Junghanss Michael Boeckh Rachel A Carter Brenda M Sandmaier Michael B Maris David G Maloney Thomas Chauncey Peter A McSweeney Marie-Térèse Little Lawrence Corey Rainer Storb

Blood 2002 Mar;99(6):1978-85

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109-1024, USA.

View Article and Find Full Text PDF

March 2002

Publications by authors named "Thomas Chauncey"

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors: